Gail H. Vance

23.7k total citations · 6 hit papers
119 papers, 10.8k citations indexed

About

Gail H. Vance is a scholar working on Genetics, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Gail H. Vance has authored 119 papers receiving a total of 10.8k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Genetics, 34 papers in Molecular Biology and 27 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Gail H. Vance's work include Genomic variations and chromosomal abnormalities (33 papers), Prenatal Screening and Diagnostics (19 papers) and Acute Myeloid Leukemia Research (13 papers). Gail H. Vance is often cited by papers focused on Genomic variations and chromosomal abnormalities (33 papers), Prenatal Screening and Diagnostics (19 papers) and Acute Myeloid Leukemia Research (13 papers). Gail H. Vance collaborates with scholars based in United States, United Kingdom and Germany. Gail H. Vance's co-authors include Patrick L. Fitzgibbons, John M.S. Bartlett, Patricia A. Spears, Pamela B. Mangu, Mitch Dowsett, Michael Bilous, Michael F. Press, Lisa M. McShane, Giuseppe Viale and Antonio C. Wolff and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Gail H. Vance

115 papers receiving 10.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update

2013 3.1k citations Antonio C. Wolff, M. Elizabeth Hammond et al. Journal of Clinical Oncology profile →
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update

2018 1.5k citations Antonio C. Wolff, M. Elizabeth Hammond et al. Journal of Clinical Oncology profile →
Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update

2013 1.3k citations Antonio C. Wolff, M. Elizabeth Hammond et al. Archives of Pathology & Laboratory Medicine profile →
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update

2018 1.0k citations Antonio C. Wolff, M. Elizabeth Hammond et al. Archives of Pathology & Laboratory Medicine profile →
Multiplex PCR: Critical Parameters and Step-by-Step Protocol

1997 743 citations Octavian Henegariu, Nyla A. Heerema et al. profile →
Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial

2006 502 citations Anthony V. Moorman, Christine J. Harrison et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gail H. Vance United States	33	5.6k	3.5k	2.9k	2.3k	1.6k	119	10.8k
Masayuki Noguchi Japan	56	5.4k 1.0×	2.1k 0.6×	4.2k 1.5×	1.6k 0.7×	5.4k 3.3×	352	16.8k
Clive R. Taylor United States	53	4.4k 0.8×	1.2k 0.3×	3.3k 1.2×	1.5k 0.7×	1.5k 0.9×	231	11.4k
Takehiko Sasazuki Japan	71	2.9k 0.5×	1.7k 0.5×	5.8k 2.0×	1.0k 0.5×	1.2k 0.7×	351	18.7k
Giorgio Cattoretti Italy	54	4.2k 0.7×	1.9k 0.5×	6.6k 2.3×	830 0.4×	845 0.5×	183	16.3k
Daniel E. Speiser Switzerland	77	10.7k 1.9×	1.9k 0.5×	6.4k 2.2×	928 0.4×	1.3k 0.8×	310	23.1k
Hilmar Lemke Germany	33	3.4k 0.6×	1.3k 0.4×	3.4k 1.2×	2.1k 0.9×	1.3k 0.8×	74	12.2k
Thomas J. Schall United States	75	10.3k 1.8×	905 0.3×	4.3k 1.5×	1.2k 0.5×	2.0k 1.2×	185	25.8k
Vassiliki A. Boussiotis United States	61	5.5k 1.0×	1.3k 0.4×	3.8k 1.3×	575 0.3×	883 0.5×	182	15.6k
Ignacio Melero Spain	88	15.8k 2.8×	2.4k 0.7×	6.6k 2.3×	1.6k 0.7×	3.0k 1.9×	396	28.2k
Jeffrey W. Clark United States	67	7.7k 1.4×	2.8k 0.8×	4.4k 1.5×	701 0.3×	4.6k 2.8×	351	16.8k

Countries citing papers authored by Gail H. Vance

Since Specialization

Citations

This map shows the geographic impact of Gail H. Vance's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gail H. Vance with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gail H. Vance more than expected).

Fields of papers citing papers by Gail H. Vance

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gail H. Vance. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gail H. Vance. The network helps show where Gail H. Vance may publish in the future.

Co-authorship network of co-authors of Gail H. Vance

This figure shows the co-authorship network connecting the top 25 collaborators of Gail H. Vance. A scholar is included among the top collaborators of Gail H. Vance based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gail H. Vance. Gail H. Vance is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vance, Gail H., et al.. (2025). Increased Prevalence of Psychiatric Conditions in Panniculectomy Patients With Prior Bariatric Surgery: A Nationwide Epic Cosmos Study. Cureus. 17(1). e77321–e77321. 1 indexed citations

Schroeder, Christopher, et al.. (2024). Referral patterns and genetic testing outcomes in a contemporary hereditary renal cancer clinic. Urologic Oncology Seminars and Original Investigations. 42(3). 72.e19–72.e25.

Wolff, Antonio C., M. Elizabeth Hammond, Kimberly H. Allison, et al.. (2018). Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update. Journal of Clinical Oncology. 36(20). 2105–2122. 1545 indexed citations breakdown →

Strickland, Stephen A., Zhuoxin Sun, Rhett P. Ketterling, et al.. (2017). Independent Prognostic Significance of Monosomy 17 and Impact of Karyotype Complexity in Monosomal Karyotype/Complex Karyotype Acute Myeloid Leukemia: Results from Four ECOG-ACRIN Prospective Therapeutic Trials. Leukemia Research. 59. 55–64. 13 indexed citations

Virts, Elizabeth L., Anna Jankowska, Constanze Wiek, et al.. (2016). Complementation of hypersensitivity to DNA interstrand crosslinking agents demonstrates that XRCC2 is a Fanconi anaemia gene. PMC. 6 indexed citations

Chakraborty, Sujata, et al.. (2014). Therapy-related myeloid neoplasm with bone marrow involvement, myelosarcoma, and a t(8;16)(p11.2;p13.3)—a case report. Cancer Genetics. 207(10-12). 511–515. 2 indexed citations

Schneider, Bryan P., Robert J. Gray, Milan Radovich, et al.. (2013). Prognostic and Predictive Value of Tumor Vascular Endothelial Growth Factor Gene Amplification in Metastatic Breast Cancer Treated with Paclitaxel with and without Bevacizumab; Results from ECOG 2100 Trial. Clinical Cancer Research. 19(5). 1281–1289. 47 indexed citations

Weaver, David D., et al.. (2013). Positive cell-free fetal DNA testing for trisomy 13 reveals confined placental mosaicism. Genetics in Medicine. 15(9). 729–732. 57 indexed citations

Zhang, Qing, Shaochun Bai, & Gail H. Vance. (2013). Molecular Genetic Tests for FLT3, NPM1, and CEBPA in Acute Myeloid Leukemia. Methods in molecular biology. 999. 105–121. 2 indexed citations

10.

Vance, Gail H., Barbara Janowitz, Bret A. Boyer, et al.. (2013). Integrating family planning messages into immunization services: a cluster-randomized trial in Ghana and Zambia. Health Policy and Planning. 29(3). 359–366. 35 indexed citations

11.

Gökmen‐Polar, Yesim, Kerry L. Sanders, Chirayu Goswami, et al.. (2012). Establishment and characterization of a novel cell line derived from human thymoma AB tumor. Laboratory Investigation. 92(11). 1564–1573. 20 indexed citations

12.

Wetherill, Leah, et al.. (2010). Referral Patterns of Indiana Oncologists for Colorectal Cancer Genetic Services. Journal of Cancer Education. 25(1). 92–95. 4 indexed citations

13.

Grimes, Brenda R., Stephanie Merfeld‐Clauss, Dmitry O. Traktuev, et al.. (2008). Interphase FISH Demonstrates that Human Adipose Stromal Cells Maintain a High Level of Genomic Stability in Long-Term Culture. Stem Cells and Development. 18(5). 717–724. 37 indexed citations

14.

Farrow, Emily, et al.. (2007). A case of de novo partial tetrasomy of distal 6p and review of the literature. American Journal of Medical Genetics Part A. 143A(17). 1978–1983. 13 indexed citations

15.

Moorman, Anthony V., Christine J. Harrison, Georgina Buck, et al.. (2006). Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial. Blood. 109(8). 3189–3197. 502 indexed citations breakdown →

16.

Caudill, Samuel P., Daniel L. Van Dyke, Andrew T. L. Chen, et al.. (2005). Evaluating current policy for detecting mosaicism in amniotic fluid cultures: implications for current cell counting practices. Statistics in Medicine. 24(4). 615–622. 1 indexed citations

17.

Nagle, Raymond B., Patrick C. Roche, Eric D. Hsi, et al.. (2002). Clinical laboratory assays for HER-2/neu amplification and overexpression: Quality assurance, standardization, and proficiency testing. Archives of Pathology & Laboratory Medicine. 126(7). 803–808. 65 indexed citations

18.

Brensinger, Jill D., Steven J. Laken, Michael C. Luce, et al.. (1998). Variable phenotype of familial adenomatous polyposis in pedigrees with 3′ mutation in the APC gene. Gut. 43(4). 548–552. 91 indexed citations

19.

Henegariu, Octavian, Nyla A. Heerema, S. R. Dlouhy, Gail H. Vance, & P. H. Vogt. (1997). Multiplex PCR: Critical Parameters and Step-by-Step Protocol. IUScholarWorks (Indiana University). 33 indexed citations

20.

Sekhar, G. Chandra, et al.. (1994). Ocular manifestations of Hansen's disease. Documenta Ophthalmologica. 87(3). 211–221. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact